搜索
BALANCESHEET((PREPAREDINACCORDANCEWITHPRCACCOUNTINGSTANDARDS)129ShandongXinhuaPharmaceuticalCompanyLimitedAnnualReport2003ASSETSConsolidatedParentcompany20031231200212312003123120021231ATENDATBEGINNINGATENDATBEGINNINGOFYEAROFYEAROFYEAROFYEARNOTESRMBRMBRMBRMBCURRENTASSETSMonetaryFund5413,986,014.30503,467,118.60399,368,092.85495,429,329.13Short-terminvestments631,177,842.00—31,177,842.00—Notesreceivable740,950,704.9713,256,368.2040,950,704.9713,256,368.20Dividendreceivable————Interestreceiveble————Accountsreceivable8259,673,380.86252,888,637.49259,623,380.86252,888,637.49Otherreceivables9104,258,510.22117,596,866.22105,353,651.38116,167,668.67AccountsPrepaid104,157,098.073,401,774.744,147,040.783,152,474.52Inventories11250,537,957.72218,634,068.33244,114,271.13213,030,993.62Deferredandprepaidexpenses————Long-termdebtinvestmentduewithinayear————Othercurrentassets————Totalcurrentassets1,104,741,508.141,109,244,833.581,084,734,983.971,093,925,471.63LONG-TERMINVESTMETSLong-termequityinvestment1280,108,518.0055,277,318.0092,010,811.7763,208,974.89Long-termdebtinvestment1275,500.0075,500.0075,500.0075,500.00Totallong-terminvestmets80,184,018.0055,352,818.0092,086,311.7763,284,474.89FIXEDASSETSFixedassets-cost131,352,596,074.871,085,199,625.041,350,370,160.861,084,485,074.04Less:accumulateddepreciation13653,386,788.34585,157,010.10653,008,602.18584,956,320.84Fixedassetsnet13699,209,286.53500,042,614.94697,361,558.68499,528,753.20Less:Provisionforimpainment13fixedassets————Fixedassetsnet13699,209,286.53500,042,614.94697,361,558.68499,528,753.20Constructionmaterials10,206,048.738,558,149.8310,206,048.738,558,149.83Construction-in-progress14120,597,120.29154,740,709.72120,597,120.29154,740,709.72Totalfixedassets830,012,455.55663,341,474.49828,164,727.70662,827,612.75INTANGIBLEASSESTSANDOTHERASSETSIntangibleassets1570,442,662.7868,331,382.5670,442,662.7868,331,382.56Long-termprepayments————Otherlong-termassets————Totalintangibleassetsandotherassets70,442,662.7868,331,382.5670,442,662.7868,331,382.56DEFEREDTAXDeferedtaxdebit————TOTALASSETS2,085,380,644.471,896,270,508.632,075,428,686.221,888,368,941.83BALANCESHEET(continued)130((PREPAREDINACCORDANCEWITHPRCACCOUNTINGSTANDARDS)LIABILITIESANDCAPITALConsolidatedParentcompany20031231200212312003123120021231ATENDATBEGINNINGATENDATBEGINNINGOFYEAROFYEAROFYEAROFYEARNOTESRMBRMBRMBRMBCURRENTLIABILITESShort-termloans16174,156,000.00140,000,000.00174,156,000.00140,000,000.00Notespayable1792,199,948.186,800,000.0092,199,948.186,800,000.00Accountspayable18145,346,593.63110,077,846.60140,368,400.07104,682,406.00Depositsfromcustomers198,541,346.036,794,110.568,541,346.036,649,110.56Accruedpayroll————LongtermliabilitiesWelfare&benefitpayable12,789,206.449,832,743.4012,789,206.449,832,743.40Dividendspayable205,795,059.075,135,547.705,795,059.075,135,547.70Taxespayable21(19,525,415.51)(22,029,554.22)(19,201,318.56)(21,331,654.46)Otherpayments————Otherpayables2237,941,290.8932,499,211.3137,355,557.1532,116,375.97Accruedexpenses237,302,547.673,000,000.007,302,547.673,000,000.00Estimatedliabilities————Longtermliabilitiesduewihtinoneyear24—200,000,000.00—200,000,000.00Othercurrentliabilities————Totalcurrentliabilities464,546,576.40492,109,905.35459,306,746.05486,884,529.17LONG-TERMLIABILITIESLong-termborrowings25200,000,000.00—200,000,000.00—Bondspayable————Long-termpayable————Otherlong-termliabilities3,561,500.003,561,500.003,561,500.003,561,500.00Totallongtermliabilities203,561,500.003,561,500.00203,561,500.003,561,500.00DEFEREDTAXDeferedtaxcredit————Totalliabilities668,108,076.40495,671,405.35662,868,246.05490,446,029.17MINORITYSHAREHOLDERS’EQUITYMinorityShareholders’Equity263,968,071.032,676,190.62——SHARECAPITALEQUITYSharecapital27457,312,830.00457,312,830.00457,312,830.00457,312,830.00Capitalsurplus28558,919,077.15558,919,077.15558,919,077.15558,919,077.15Surplusreserve29159,424,924.74148,905,850.41159,216,915.99148,697,841.66:Including:welfarefund2926,291,986.9124,188,172.0426,222,650.6624,118,835.79Undistributedprofit30236,903,608.28232,785,155.10237,111,617.03232,993,163.85Including:Dividendincashtobedistributed18,292,513.2027,438,769.8018,292,513.2027,438,769.80Foreigncurrencystatementtranslationdifference31744,056.87———Totalsharecapitalequity1,413,304,497.041,397,922,912.661,412,560,440.171,397,922,912.66Totalliabilities&stockholdersequity2,085,380,644.471,896,270,508.632,075,428,686.221,888,368,941.83PROFITANDLOSSACCOUNTANDPROFITDISTRIBUTION((PREPAREDINACCORDANCEWITHPRCACCOUNTINGSTANDARDS)131ShandongXinhuaPharmaceuticalCompanyLimitedAnnualReport2003ItemsConsolidatedParentcompany2003200220032002CURRENTYEARLASTYEARCURRENTYEARLASTYEARCUMULATIVECUMULATIVECUMULATIVECUMULATIVENOTESRMBRMBRMBRMB.Revenuefrommainoperations321,328,471,339.171,173,549,986.461,308,531,616.751,157,258,610.49Less:Costofmainoperations321,027,612,757.59858,629,236.451,014,477,760.60847,023,403.90Taxandsurchargesformainoperations338,227,711.083,188,801.117,988,780.343,013,539.28.Salesgrossprofit292,630,870.50311,731,